Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOTAREM vs Gadovist for contrast-enhanced MRA in peripheral arterial disease
2009-011002-42Phase 4Completed
- Sponsor
- Guerbet
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of gadoterate meglumine in peripheral artery occlusion (PAD) (2 arms), sponsored by Guerbet. Primary endpoint: Overall image quality of each MRA examination. Started Apr 2009; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2009-011002-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011002-42.